首页 › 非肌层浸润性膀胱癌 › 阿拉巴马州 › Birmingham
Birmingham AL 非肌层浸润性膀胱癌临床试验
7项针对 非肌层浸润性膀胱癌的研究正在 Birmingham及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
招募中3 期
- University of Alabama at Birmingham Cancer Center, Birmingham
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
招募中2 期
- Urology Centers of Alabama, Homewood · 距离 3 英里
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
招募中1 期
- The Kirklin Clinic of UAB Hospital, Birmingham
- UAB Infusion Therapy Extended Care Clinic (ECC), Birmingham
- The University of Alabama at Birmingham Investigation Drug Services Pharmacy, Birmingham
- 以及另外 1 项
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
招募中观察性研究
- University of Alabama at Birmingham, Birmingham
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
招募中2 期
- Urology Centers of Alabama, Homewood · 距离 3 英里
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
招募中1/2 期
- The University of Alabama at Birmingham Clinical Research Unit (CRU), Birmingham
Blue Light Cystoscopy With Cysview® Registry
招募中观察性研究
- The University of Alabama at Birmingham, Birmingham
其他城市的 非肌层浸润性膀胱癌试验
- Columbus, OH10 项研究
- Dallas, TX10 项研究
- New York City, NY10 项研究
- Myrtle Beach, SC9 项研究
- Edison, NJ9 项研究
- Baltimore, MD8 项研究
- Syracuse, NY8 项研究
- Nashville, TN8 项研究
- Houston, TX7 项研究
- Indianapolis, IN7 项研究
- Philadelphia, PA7 项研究
- Atlanta, GA7 项研究
Birmingham的其他研究
- 癌症（所有类型）31 项研究
- 乳腺癌24 项研究
- 卵巢癌23 项研究
- 肥胖症23 项研究
- 非小细胞肺癌22 项研究
- 急性髓系白血病21 项研究
- 多发性骨髓瘤18 项研究
- 慢性阻塞性肺病17 项研究
- 心血管疾病17 项研究
- 2型糖尿病16 项研究
- 子宫内膜癌16 项研究
- 超重16 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。